A

Advanced Pharma CR | Miami, FL

Research site

(Unclaimed)

Location

2950 NW 83rd St, Miami, Florida, United States of America

Site insights

Top conditions

Top treatments

INCB050465

S-217622

Ruxolitinib

Bococizumab

ASP0367

Filgotinib

Pregabalin

Dapagliflozin

ION224

Brazikumab

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

5 of 82 total trials

A Study of Etavopivat in Adults and Adolescents With Sickle Cell Disease (HIBISCUS)

This clinical trial is a Phase 2/3 study that will evaluate the efficacy and safety of etavopivat and test how well etavopivat works compared to plac...

Active, not recruiting

Sickle Cell Disease

Drug: Placebo Tablets

Drug: Etavopivat Tablets High dose

A Study of LY4213663 in Healthy Participants and Participants With Rheumatoid Arthritis

The purpose of this study is to evaluate how well LY4213663 is tolerated and what side effects may occur in healthy participants and participants wit...

Enrolling

Healthy

Rheumatoid Arthritis (RA)

Drug: LY4213663

Drug: Placebo

A Study to Evaluate the Long-Term Safety and Efficacy of Upadacitinib (ABT-494) in Participants With Ulcerative Colitis (UC) (U-ACTIVATE)

This study is designed to evaluate the long-term safety and efficacy of Upadacitinib in participants with ulcerative colitis (UC) who have not respon...

Active, not recruiting

Ulcerative Colitis (UC)

Drug: Placebo

Drug: Upadacitinib (ABT-494)

Multiple Dose Study of MK-2828 in Participants With Type 2 Diabetes (MK-2828-003)

The purpose of this study is to learn about the safety and if people tolerate a study medicine called MK-2828. The study will also measure what happe...

Enrolling

Diabetes Mellitus, Type 2

Drug: MK-2828

Drug: Placebo

SAD Study to Evaluate Safety, Tolerability, and Pharmacokinetic Profile of KSHN001126 in Healthy Post-Menopausal Females

This is an Open-label, Sequential dosing, Single Ascending Dose (SAD) Study to Determine the Safety, Tolerability, and Pharmacokinetic (PK) Profile o...

Not yet enrolling

Healthy Postmenopausal Women

Drug: KSHN001126 150mg

Drug: KSHN001126 600mg